265 related articles for article (PubMed ID: 1386152)
1. [Kynurenine and its metabolites in nervous system diseases].
Vécsei L; Schwab F
Orv Hetil; 1992 Jul; 133(29):1803-7. PubMed ID: 1386152
[TBL] [Abstract][Full Text] [Related]
2. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
4. Kynurenine metabolism in multiple sclerosis.
Hartai Z; Klivenyi P; Janaky T; Penke B; Dux L; Vecsei L
Acta Neurol Scand; 2005 Aug; 112(2):93-6. PubMed ID: 16008534
[TBL] [Abstract][Full Text] [Related]
5. Neuropharmacology of quinolinic and kynurenic acids.
Stone TW
Pharmacol Rev; 1993 Sep; 45(3):309-79. PubMed ID: 8248282
[TBL] [Abstract][Full Text] [Related]
6. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
[TBL] [Abstract][Full Text] [Related]
7. The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations.
Tan L; Yu JT; Tan L
J Neurol Sci; 2012 Dec; 323(1-2):1-8. PubMed ID: 22939820
[TBL] [Abstract][Full Text] [Related]
8. A review of chromatographic methods for bioactive tryptophan metabolites, kynurenine, kynurenic acid, quinolinic acid, and others, in biological fluids.
Fukushima T; Umino M; Sakamoto T; Onozato M
Biomed Chromatogr; 2022 May; 36(5):e5308. PubMed ID: 34978092
[TBL] [Abstract][Full Text] [Related]
9. Hypothesis kynurenic and quinolinic acids: The main players of the kynurenine pathway and opponents in inflammatory disease.
Badawy AA
Med Hypotheses; 2018 Sep; 118():129-138. PubMed ID: 30037600
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid levels of kynurenine pathway metabolites in patients with eating disorders: relation to clinical and biochemical variable.
Demitrack MA; Heyes MP; Altemus M; Pigott TA; Gold PW
Biol Psychiatry; 1995 Apr; 37(8):512-20. PubMed ID: 7542489
[TBL] [Abstract][Full Text] [Related]
11. Increased ratio of quinolinic acid to kynurenic acid in cerebrospinal fluid of D retrovirus-infected rhesus macaques: relationship to clinical and viral status.
Heyes MP; Mefford IN; Quearry BJ; Dedhia M; Lackner A
Ann Neurol; 1990 Jun; 27(6):666-75. PubMed ID: 2163238
[TBL] [Abstract][Full Text] [Related]
12. Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington's disease.
Sapko MT; Guidetti P; Yu P; Tagle DA; Pellicciari R; Schwarcz R
Exp Neurol; 2006 Jan; 197(1):31-40. PubMed ID: 16099455
[TBL] [Abstract][Full Text] [Related]
13. The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection.
Vamos E; Pardutz A; Klivenyi P; Toldi J; Vecsei L
J Neurol Sci; 2009 Aug; 283(1-2):21-7. PubMed ID: 19268309
[TBL] [Abstract][Full Text] [Related]
14. Kynurenine production and catabolism in fetal sheep with embolized or nonembolized placentas.
Nicholls T; Nitsos I; Smythe G; Walker DW
Am J Obstet Gynecol; 2001 Oct; 185(4):988-95. PubMed ID: 11641690
[TBL] [Abstract][Full Text] [Related]
15. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
[TBL] [Abstract][Full Text] [Related]
16. [Biochemical studies on AIDS dementia complex--possible contribution of quinolinic acid during brain damage].
Saito K
Rinsho Byori; 1995 Sep; 43(9):891-901. PubMed ID: 7474452
[TBL] [Abstract][Full Text] [Related]
17. Tryptophan metabolism in the central nervous system: medical implications.
Ruddick JP; Evans AK; Nutt DJ; Lightman SL; Rook GA; Lowry CA
Expert Rev Mol Med; 2006 Aug; 8(20):1-27. PubMed ID: 16942634
[TBL] [Abstract][Full Text] [Related]
18. [Enzymes of the kynurenine pathway].
Tankiewicz A; Pawlak D; Buczko W
Postepy Hig Med Dosw; 2001; 55(5):715-31. PubMed ID: 11795205
[TBL] [Abstract][Full Text] [Related]
19. Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.
Lovelace MD; Varney B; Sundaram G; Lennon MJ; Lim CK; Jacobs K; Guillemin GJ; Brew BJ
Neuropharmacology; 2017 Jan; 112(Pt B):373-388. PubMed ID: 26995730
[TBL] [Abstract][Full Text] [Related]
20. Production of quinolinic acid and kynurenic acid by human glioma.
Vezzani A; Gramsbergen JB; Speciale C; Schwarcz R
Adv Exp Med Biol; 1991; 294():691-5. PubMed ID: 1837700
[No Abstract] [Full Text] [Related]
[Next] [New Search]